Literature DB >> 9808151

Receptor tyrosine kinase expression in human bone marrow stromal cells.

K Satomura1, A R Derubeis, N S Fedarko, K Ibaraki-O'Connor, S A Kuznetsov, D W Rowe, M F Young, P Gehron Robey.   

Abstract

Bone marrow stromal cells (BMSCs) are a heterogeneous population of cells derived from colony-forming units-fibroblastic (CFU-Fs). These cells reside in the bone marrow cavity and are capable of differentiating into several cell phenotypes including osteoblasts, chondroblasts, hematopoiesis-supporting stromal cells, and adipocytes. However, the factors that regulate the proliferation and differentiation of the BMSC population are for the most part unknown. Since many members of the receptor tyrosine kinase (RTK) family have been shown to participate in growth control of various mesenchymal cell populations, in this study we examined the expression and function of RTKs in the BMSC population. Degenerate oligonucleotides corresponding to two conserved catalytic domains of the RTK family and RT-PCR were used initially to determine which RTKs are expressed in the human BMSC (hBMSC) system. After subcloning the amplification product generated from mRNA of a multicolony-derived hBMSC strain, PDGF receptor (beta), EGF receptor, FGF receptor 1, and Axl were identified by DNA sequencing of 26 bacterial colonies. Furthermore, PDGF and EGF were found to enhance BMSC growth in a dose-dependent manner and to induce tyrosine phosphorylation of intracellular molecules, including the PDGF and EGF receptors themselves, demonstrating the functionality of these receptors. On the other hand, bFGF was found to have little effect on proliferation or tyrosine phosphorylation. Since single colony-derived hBMSC strains are known to vary from one colony to another in colony habit (growth rate and colony structure) and the ability to form bone in vivo, the expression levels of these RTKs were determined in 18 hBMSC clonal strains by semiquantitative RT-PCR and were found to vary from one clonal strain to another. While not absolutely predictive of the osteogenic capacity of individual clonal strains, on average, relatively high levels of PDGF-receptor were found in bone-forming strains, while on average, nonbone-forming strains had relatively high levels of EGF-receptor. Taken together, these results indicate that RTKs play a role in the control of hBMSC proliferation, and that the differential pattern of RTK expression may be useful in correlating the biochemical properties of individual clonal strains with their ability to produce bone in vivo.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1998        PMID: 9808151     DOI: 10.1002/(SICI)1097-4652(199812)177:3<426::AID-JCP6>3.0.CO;2-F

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  31 in total

1.  Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factor.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Tal Hammer-Topaz; Yifat Cohen; Felix Mor; Gerard Wagemaker; Arnon Nagler; Irun Robert Cohen; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

Review 2.  Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC.

Authors:  Kenichi Tamama; Haruhisa Kawasaki; Alan Wells
Journal:  J Biomed Biotechnol       Date:  2010-02-17

3.  Molecular profile of clonal strains of human skeletal stem/progenitor cells with different potencies.

Authors:  Brian J Sworder; Sayuri Yoshizawa; Prasun J Mishra; Natasha Cherman; Sergei A Kuznetsov; Glenn Merlino; Arun Balakumaran; Pamela G Robey
Journal:  Stem Cell Res       Date:  2015-02-25       Impact factor: 2.020

Review 4.  In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment.

Authors:  Wendy S Vanden Berg-Foels
Journal:  Tissue Eng Part B Rev       Date:  2013-07-11       Impact factor: 6.389

5.  Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function.

Authors:  Jeremy L Herrmann; Aaron M Abarbanell; Brent R Weil; Yue Wang; Jeffrey A Poynter; Mariuxi C Manukyan; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-19       Impact factor: 3.619

6.  Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Zhiliang Wu; Watcharin Loilome; Paiboon Sithithaworn; Isao Nagano; Somchai Pinlaor; Puangrat Yongvanit; Phuangphaka Sadee Nielsen; Chawalit Pairojkul; Narong Khuntikeo
Journal:  Tumour Biol       Date:  2012-06-26

Review 7.  Bone repair with skeletal stem cells: rationale, progress to date and clinical application.

Authors:  Elena A Jones; Peter V Giannoudis; Dimitrios Kouroupis
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-01       Impact factor: 5.346

8.  Quantitative proteomics analysis of chondrogenic differentiation of C3H10T1/2 mesenchymal stem cells by iTRAQ labeling coupled with on-line two-dimensional LC/MS/MS.

Authors:  Yu-hua Ji; Ju-ling Ji; Fen-yong Sun; Yao-ying Zeng; Xian-hui He; Jing-xian Zhao; Yu Yu; Shou-he Yu; Wei Wu
Journal:  Mol Cell Proteomics       Date:  2009-12-15       Impact factor: 5.911

9.  Proline-rich hypothalamic polypeptide has opposite effects on the proliferation of human normal bone marrow stromal cells and human giant-cell tumour stromal cells.

Authors:  R K Chailakhyan; Yu V Gerasimov; M R Chailakhyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2010-01-20       Impact factor: 3.996

10.  Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction.

Authors:  Katarina Kollar; Matthew M Cook; Kerry Atkinson; Gary Brooke
Journal:  Int J Cell Biol       Date:  2009-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.